Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) announced a quarterly dividend on Thursday, February 20th, Wall Street Journal reports. Stockholders of record on Tuesday, March 4th will be paid a dividend of 0.12 per share on Tuesday, March 18th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date of this dividend is Tuesday, March 4th. This is a positive change from Ryan Specialty’s previous quarterly dividend of $0.11.
Ryan Specialty has a dividend payout ratio of 16.4% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Ryan Specialty to earn $2.77 per share next year, which means the company should continue to be able to cover its $0.44 annual dividend with an expected future payout ratio of 15.9%.
Ryan Specialty Stock Down 4.4 %
NYSE RYAN opened at $65.55 on Friday. The business has a fifty day moving average price of $65.57 and a 200 day moving average price of $67.26. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $17.16 billion, a P/E ratio of 95.00, a P/E/G ratio of 1.19 and a beta of 0.72. Ryan Specialty has a one year low of $45.72 and a one year high of $75.97.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the stock. Morgan Stanley initiated coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. Wells Fargo & Company increased their price target on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday. Barclays boosted their price objective on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Royal Bank of Canada cut their target price on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday. Finally, Keefe, Bruyette & Woods reduced their price target on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a report on Friday. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and an average price target of $74.55.
Read Our Latest Report on Ryan Specialty
Insider Activity at Ryan Specialty
In related news, Director Nicholas Dominic Cortezi sold 10,485 shares of Ryan Specialty stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total value of $682,783.20. Following the completion of the sale, the director now owns 11,109 shares in the company, valued at approximately $723,418.08. This trade represents a 48.56 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders have sold 316,451 shares of company stock worth $20,907,793. Company insiders own 11.10% of the company’s stock.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- 3 Healthcare Dividend Stocks to Buy
- Gilead Sciences: 4 Reasons This Stock Has Much More To Rise
- Canadian Penny Stocks: Can They Make You Rich?
- MarketBeat Week in Review – 02/17 – 02/21
- Growth Stocks: What They Are, What They Are Not
- SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.